Sector portfolio · Government fund · United States

National Institutes of Health's Biotech portfolio

National Institutes of Health has backed 145 Biotech startups in rounds we track, $2.5B between them, shown by the stage each has reached. The best-funded is 23andme.

145startups backed
5stages
$2.5Braised between them
Stage not reportedbiggest stage

National Institutes of Health's whole portfolioNational Institutes of Health's profile

Stage not reported

113

+89 more

Series B

10

Series A

8

Pre-seed and seed

8

Series C and later

6

Segment by segment

Stage not reported

113 startups · $702M raised

  1. Global Registry of BiorepositoriesThe Global Registry of Biorepositories is a clearing house of information on biological collections in biorepositories.Denmark$45M
  2. NNERINERI is a research organization delivering customized research and clinical trial solutions to private public-sector organizations.United States$45M
  3. LUCID DIAGNOSTICS INC.Lucid Diagnostics develops a non-invasive, office based diagnostic test for biomarkers to esophageal cancer.United States$45M
  4. Akonni BiosystemsAkonni Biosystems is a biotechnology company that develops and manufactures, genetic testing devices.United States$45M
  5. Sparian BiosciencesSparian Biosciences is a biopharmaceutical company.United States$35M
  6. Trefoil TherapeuticsTrefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases.United States$33M
  7. Clene NanomedicineClene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.United States$32M
  8. MAIA BiotechnologyMAIA Biotechnology is a clinical-stage biopharmaceutical company developing cancer therapies that target telomeres through immunotherapy.United States$30M

Series B

10 startups · $298M raised

  1. NoomNoom is a prominent digital health company based in New York City, founded in 2008 by Saeju Jeong and Artem Petakov.United States$86M
  2. Windgap MedicalWindGap Medical is a biotech company that manufactures medical devices used to treat patients with severe allergies.United States$70M
  3. Allyx TherapeuticsAllyx Therapeutics is a clinical-stage biotechnology company based in New Haven, Connecticut, founded in 2019.United States$61M
  4. NanopathNanopath Inc.United States$25M
  5. Kinoxis TherapeuticsKinoxis Therapeutics is a biotechnology company that develops a range of novel therapeutic compounds.Australia$14M
  6. iotaMotionIotaMotion is a medical technology company developing robotics-assisted solutions for cochlear implant surgery.United States$13M
  7. SonoMotionSonomotion is a medical device manufacturing company that specializes in providing medical solutions for kidney stones disease.United States$12M
  8. Cell MicrosystemsCell Microsystems is a biotechnology company based in Durham, North Carolina, founded in 2010.United States$6.5M

Series A

8 startups · $189M raised

  1. ProLynxProlynx is a clinical-stage biotechnology company based in the San Francisco Bay Area, founded in 2009.United States$70M
  2. AzitraAzitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.United States$49M
  3. Artio MedicalArtio Medical develops endovascular medical devices for the embolization of vessels, aneurysms, and other vascular structures.United States$28M
  4. Fesarius TherapeuticsFesarius Therapeutics is a bioregenerative medical technology company based in New York, founded in 2015 by Dr.United States$21M
  5. SEngine Precision MedicineSEngine Precision Medicine uses algorithms and 3D organoid technology to develop drugs with more efficacy.United States$10M
  6. NovosteoNovosteo, test the efficacy of a new drug to help reduce complications from a broken bone due to a fall.-$5.5M
  7. CSCordex SystemsUnited States$5.0M
  8. Trace BiosciencesTrace Biosciences is a biotechnology startup founded in 2019, focused on developing targeted imaging agents that enhance nerve visUnited States$300K

Pre-seed and seed

8 startups · $47M raised

  1. Fauna BioFauna Bio is an AI-driven biotechnology company founded in 2018, based in Emeryville, California, with an additional office in Berkeley.United States$13M
  2. PsileraPsilera is a biopharmaceutical company founded in 2019, focused on developing innovative neuroplastogens, non-hallucinogenic compouUnited States$11M
  3. Immuto ScientificImmuto Scientific is a biotechnology company founded in 2018, with locations in Madison, Wisconsin, and Cambridge, Massachusetts.United States$8.0M
  4. Partillion BiosciencePartillion Bioscience is an early-stage life science company developing a functional single-cell analysis platform.United States$7.1M
  5. ATAdvent TherapeuticsAdvent Therapeutics is focused on providing therapies for micro-orphan applications.United States$3.0M
  6. dfusiondfusion, a team of scientists and innovators, develops technology to promote evidence-based, health-related behavioral changes.United States$2.8M
  7. Sedia BiosciencesSedia Biosciences develops and sells medical diagnostic tests and monitoring tools used to battle against pandemics.United States$1.5M
  8. O2 RegenTechOur novel platform biopolymer technology, OXAIDTM, will be the first on the market to combine the benefits of providing oxygen witUnited States$250K

Series C and later

6 startups · $1.3B raised

  1. 23andMeUnited States$729M
  2. Recursion PharmaceuticalsRecursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.United States$339M
  3. ONL TherapeuticsONL Therapeutics is a clinical-stage biopharmaceutical company based in Ann Arbor, Michigan, founded in 2011.United States$67M
  4. SeLux DiagnosticsSeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.United States$48M
  5. Symic BioSymic Bio is a biopharmaceutical company based in San Francisco, California, founded in 2012.United States$41M
  6. Airway TherapeuticsAirway Therapeutics is a clinical-stage biopharmaceutical company based in Cincinnati, Ohio, founded in 2011 as a spin-out from CiUnited States$29M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names National Institutes of Health as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioNational Institutes of Health's Healthtech portfolio46 startups · $487MSector portfolioNational Institutes of Health's AI portfolio15 startups · $107MPortfolio mapNational Institutes of Health portfolio map232 startups · $3.3BCo-investorsWho invests with National Institutes of Health42 co-investorsSector portfolioNational Science Foundation's Biotech portfolio250 startups · $2.0BSector portfolioNational Science Foundation's Healthtech portfolio149 startups · $516M

Raising from investors like National Institutes of Health?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps